- Company's common stock ceased trading on the New York Stock Exchange, effective January 28, 2016.
The world’s largest private equity investor in real estate will pay $23.75 a share in cash, according to a statement Thursday. That’s about 24 percent more than BioMed’s closing share price on Sept. 22, the day before Bloomberg reported that the San Diego-based real estate investment trust was working with Morgan Stanley to explore a sale.
No comments:
Post a Comment